Skip to main content

Table 1 Baseline characteristics of subjects regarding different combinations of glucose tolerance statuses and general obesity among men

From: The impact of obesity on different glucose tolerance status with incident cardiovascular disease and mortality events over 15 years of follow-up: a pooled cohort analysis

Variables

NGT

Pre-diabetes

Type 2 diabetes

Non-obese (n = 3918)

Obese (n = 1057)

Non-obese (n = 1828)

Obese (n = 736)

Non-obese (n = 379)

Obese (n = 339)

Age (years)

49.0 (7.6)

49.6 (7.4)

51.9 (5.6)

51.2 (5.8)

52.7 (6.0)

52.6 (5.7)

SBP (mmHg)

115.0 (15.8)

122.2 (18.1)

120.9 (17.4)

124.9 (16.1)

126.2 (20.9)

129.4 (18.5)

DBP (mmHg)

72.9 (10.7)

75.5 (11.5)

75.4 (11.2)

78.1 (11.1)

76.8 (12.5)

77.0 (11.3)

BMI (kg/m2)

25.2 (2.8)

33.8 (4.0)

26.1 (2.4)

33.7 (4.1)

26.2 (2.6)

34.7 (4.1)

WC (cm)

90.8 (9.1)

109.6 (10.5)

95.6 (7.4)

112.6 (10.6)

95.7 (7.7)

113.9 (10.4)

Non-HDL-C (mg/dl)

151.0 (126.0–178.4)

153.0 (130.5–178.3)

165.4 (141.0–191.6)

169.0 (142.6–192.6)

168.0 (140.1–193.4)

160.1 (135.0–196.2)

FPG (mg/dl)

90.0 (84.0–95.0)

90.0 (85.0–95.0)

106.0 (102.1–111.0)

106.9 (103.0–113.3)

150.0 (130.0–209.0)

154.0 (132.0–205.1)

Education, years

  < 6

217 (5.5)

45 (4.3)

51 (2.8)

27 (3.7)

28 (7.4)

17 (5.0)

 6–12

1105 (28.2)

249 (23.5)

440 (24.1)

165 (22.4)

141 (37.2)

70 (20.7)

  ≥ 12

2596 (66.3)

763 (72.2)

1337 (73.1)

544 (73.9)

210 (55.4)

252 (74.3)

Current smoker (yes)

1190 (30.4)

262 (24.8)

531 (29.1)

179 (24.3)

118 (31.1)

63 (18.6)

Hypertension (yes)

727 (18.6)

364 (34.4)

561 (30.7)

323 (43.9)

159 (41.9)

214 (63.1)

FH-CVD (yes)

718 (18.3)

301 (28.5)

195 (10.7)

119 (16.2)

58 (15.3)

80 (23.6)

Prevalent CVD (yes)

178 (4.5)

40 (3.8)

132 (7.2)

62 (8.4)

49 (12.9)

45 (13.3)

  1. Continuous variables are shown as mean (standard deviation; SD) for normal distribution and median (interquartile range: IQR) for skewed variables (e.g. FPG, non-HDL-C), and categorical variables are presented as number (%)
  2. ARIC: Atherosclerosis Risk in Communities; MESA: Multi-Ethnic Study of Atherosclerosis; TLGS: Tehran Lipid and Glucose Study; FPG: fasting plasma glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; WC: waist circumference; FPG: fasting plasma glucose; non-HDL-C: non-high-density lipoprotein cholesterol; FHCVD: family history cardiovascular disease; CVD: cardiovascular disease; normal glucose tolerance (NGT). General obesity (BMI ≥ 30 kg/m2)
  3. Normoglycemia: FPG < 100 mg/dl & no medication; pre-diabetes: FPG 100–126 mg/dl and no medication; type 2 diabetes; FPG ≥ 126 mg/dl or using medication